Assessing the safety and tolerability of a single IV dose of AZD9742 in healthy elderly male and female subjects

Study identifier:D2690C00007

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A Phase I, Double-blind, Randomized, Placebo-Controlled Study to Assess the Safety and Tolerability, and Pharmacokinetics of a Single Dose of AZD9742 in Healthy Elderly Male and Female Volunteers

Medical condition

Tolerability, Healthy, elderly

Phase

Phase 1

Healthy volunteers

Yes

Study drug

AZD9742, Placebo

Sex

All

Actual Enrollment

12

Study type

Interventional

Age

65 Years +

Date

Study Start Date: 01 Jun 2010
Primary Completion Date: 01 Jul 2010
Study Completion Date: 01 Jul 2010

Study design

Allocation: Randomized
Endpoint Classification: Safety Study
Intervention Model: Single Group Assignment
Masking: Double Blind
Primary Purpose: Treatment

Verification:

Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals

Sponsors

AstraZeneca Pharmaceuticals

Collaborators

-

Inclusion and exclusion criteria